Clinical trials query results
From Health Canada
- Medical condition:
- MALIGNANT PLEURAL MESOTHELIOMA
- Medical condition:
- ADULT FEMALE,ADULT MALE
- Drug name:
- TREMELIMUMAB
- Protocol title:
- A PHASE 2, RANDOMIZED, DOUBLE-BLIND STUDY COMPARING TREMELIMUMAB TO PLACEBO IN SECOND OR THIRD-LINE TREATMENT OF SUBJECTS WITH UNRESECTABLE PLEURAL OR PERITONEAL MALIGNANT MESOTHELIOMA
- Sponsor name:
- MEDIMMUNE LLC
- Date of no objection letter:
- 2013-08-07
- Control number:
- 166051
- Trial status:
- PENDING